| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |